Results 121 to 130 of about 933,743 (171)

IMPACT OF LEUKOCYTE INFLAMMATORY MARKERS ON OUTCOMES OF CRITICALLY ILL PATIENTS WITH GASTROINTESTINAL DISEASES. [PDF]

Arq Gastroenterol
Rocha ACR, Codes L, Sales F, Zollinger CC, Bittencourt PL.   +4 more
europepmc   +1 more source

Ketamine use in critically ill patients: a narrative review. [PDF]

Rev Bras Ter Intensiva, 2022
Midega TD, Chaves RCF, Ashihara C, Alencar RM, Queiroz VNF, Zelezoglo GR, Vilanova LCDS, Olivato GB, Cordioli RL, Bravim BA, Corrêa TD.   +10 more
europepmc   +1 more source

Evaluación de la congestión venosa sistémica en pacientes críticos [PDF]

Se realizará un estudio para evaluar el grado de congestión venosa sistémica en los pacientes críticos; la investigación es diseño descriptivo - correlacional, transversal; la población será conformada por los pacientes críticos del Hospital Regional ...
Casa Bocangel, Paola
core  

[Posterior reversible encephalopathy syndrome in critical COVID-19 patients: Report of 2 cases]. [PDF]

Rev Esp Anestesiol Reanim, 2023
Tortajada Soler JJ, Tauler Redondo MP, Garví López M, Lozano Serrano MB, López-Torres López J, Sánchez López ML.   +5 more
europepmc   +2 more sources

[Role of ultrasound in critically ill patients with heart failure] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Lozita J, Ricarte Bratti JPL, Vicentin JM, Pinto NE.   +3 more
europepmc   +1 more source

Predictive biomarkers of mortality in critically ill patients with COVID-19. [PDF]

Med Intensiva (Engl Ed), 2020
Sirvent JM, Baro A, Morales M, Sebastian P, Saiz X.   +4 more
europepmc   +1 more source

Comparison of the NUTRIC, NUTRICm and NUTRICpcr scores in critically ill patients ventilated for COVID-19. [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Luchitta C, Moretti D, Bagilet DH, Rocchetti NS, Diodati S, Gattino SP, Re MD, Settecase CJ.   +7 more
europepmc   +1 more source

[Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units]. [PDF]

Med Intensiva, 2022
Vidal-Cortés P, Díaz Santos E, Aguilar Alonso E, Amezaga Menéndez R, Ballesteros MÁ, Bodí MA, Bordejé Laguna ML, Garnacho Montero J, García Sánchez M, López Sánchez M, Martín-Loeches I, Ochagavía Calvo A, Ramírez Galleymore P, Alcántara Carmona S, Andaluz Ojeda D, Badallo Arébalo O, Barrasa González H, Borges Sa M, Castellanos-Ortega Á, Estella Á, Ferrer Roca R, Fraile Gutiérrez V, Fuset Cabanes M, Giménez-Esparza Vich C, González Iglesias C, Hernández-Tejedor A, Igeño Cano JC, Iglesias Posadilla D, Jiménez Rivera JJ, Llanos Jorge C, Llompart-Pou JA, López Camps V, Lorencio Cárdenas C, Marcos Neira P, Martín Delgado MC, Martín-Macho González M, Martín Villén L, Nuvials Casals X, Ortiz Suñer A, Quintana Díaz M, Rascado Sedes P, Recuerda Núñez M, Del Río Carbajo L, Rodríguez Aguirregabiria M, Rodríguez Oviedo A, Seijas Betolaza I, Soriano Cuesta C, Suberviola Cañas B, Vera Ching C, Vidal González Á, Zapata Fenor L, Zaragoza Crespo R.   +51 more
europepmc   +1 more source

[Achievement of pharmacokinetic/pharmacodynamic targets with linezolid therapeutic drug monitoring in critically ill patients]. [PDF]

An Sist Sanit Navar
Irigoyen Rodriguez I, Leache L, Fernández-González J, Egües A, Librero López J.   +4 more
europepmc   +1 more source